Clinical Trial Update: Povidone-Iodine for Nasal Decolonization [Phase 4]

View source ↗

Summary

Phase 4 trial assessing nasal decolonization with povidone-iodine to reduce surgical site infections and MRSA-related infections; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Methicillin-resistant Staphylococcus Aureus Infection
• Surgical Site Infection

Drugs mentioned

• Povidone-iodine (povidone-iodine)

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Surgical Wound Infection, Preoperative Care | Phase 4 | Status: COMPLETED | Results posted: 2024-11-13